Anti-PDCD1/PD-1/CD279 Antibody (Cetrelimab)
Catalog No.
F1324
Anti-PDCD1/PD-1/CD279 Antibody (Cetrelimab)
Featured Products
Cetrelimab (JNJ 63723283; JNJ 3283) is a targetedPD-1 Cetrelimab is a human IgG4κ monoclonal antibody.PD-1 Kd is 1.72 nM (HEK293 cells).PD-1 andPD-L1 andPD-L2 The interaction (IC50 Cetrelimab also stimulates peripheral T cells and increases cytokines (IFN-γ ,IL-2 ,TNF-α) levels and inhibit tumor growth in vivo.
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145 kDa
Dry ice
2050478-92-5
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
JNJ-63723283
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q15116
Human
Unconjugated
Monoclonal
Protein A
IgG4SP
ELISA, FACS, Kinetics, Functional assay, Animal Model
PDCD1 / PD-1 / CD279
Please avoid freeze-thaw cycles.